REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS

被引:432
作者
Martin, Aline [1 ]
David, Valentin [1 ]
Quarles, L. Darryl [1 ]
机构
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38163 USA
关键词
FIBROBLAST-GROWTH-FACTOR; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; CHRONIC KIDNEY-DISEASE; VITAMIN-D METABOLISM; TRANSCRIPTS ENCODING MEMBRANE; LEFT-VENTRICULAR HYPERTROPHY; FAMILIAL TUMORAL CALCINOSIS; X-LINKED HYPOPHOSPHATEMIA; FGF23; GENE-EXPRESSION; STAGE RENAL-DISEASE;
D O I
10.1152/physrev.00002.2011
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Martin A, David V, Quarles LD. Regulation and Function of the FGF23/Klotho Endocrine Pathways. Physiol Rev 92: 131-155, 2012; doi: 10.1152/physrev.00002.2011.-Calcium (Ca2+) and phosphate (PO43-) homeostasis are coordinated by systemic and local factors that regulate intestinal absorption, influx and efflux from bone, and kidney excretion and reabsorption of these ions through a complex hormonal network. Traditionally, the parathyroid hormone (PTH)/vitamin D axis provided the conceptual framework to understand mineral metabolism. PTH secreted by the parathyroid gland in response to hypocalcemia functions to maintain serum Ca2+ levels by increasing Ca2+ reabsorption and 1,25-dihydroxyvitamin D [1,25(OH)(2)D] production by the kidney, enhancing Ca2+ and PO43- intestinal absorption and increasing Ca2+ and PO43- efflux from bone, while maintaining neutral phosphate balance through phosphaturic effects. FGF23 is a recently discovered hormone, predominately produced by osteoblasts/osteocytes, whose major functions are to inhibit renal tubular phosphate reabsorption and suppress circulating 1,25(OH)(2)D levels by decreasing Cyp27b1-mediated formation and stimulating Cyp24-mediated catabolism of 1,25(OH)(2)D. FGF23 participates in a new bone/kidney axis that protects the organism from excess vitamin D and coordinates renal PO43- handling with bone mineralization/turnover. Abnormalities of FGF23 production underlie many inherited and acquired disorders of phosphate homeostasis. This review discusses the known and emerging functions of FGF23, its regulation in response to systemic and local signals, as well as the implications of FGF23 in different pathological and physiological contexts.
引用
收藏
页码:131 / 155
页数:25
相关论文
共 233 条
[1]   MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: An inhibition regulated by PHEX cleavage of ASARM [J].
Addison, William N. ;
Nakano, Yukiko ;
Loisel, Thomas ;
Crine, Phillippe ;
McKee, Marc D. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (10) :1638-1649
[2]   Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats [J].
Aizawa, H ;
Saito, Y ;
Nakamura, T ;
Inoue, M ;
Imanari, T ;
Ohyama, Y ;
Matsumura, Y ;
Masuda, H ;
Oba, S ;
Mise, N ;
Kimura, K ;
Hasegawa, A ;
Kurabayashi, M ;
Kuro-o, M ;
Nabeshima, Y ;
Nagai, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (03) :865-871
[3]   Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets [J].
Alon, Uri S. ;
Levy-Olomucki, Rachel ;
Moore, Wayne V. ;
Stubbs, Jason ;
Liu, Shiguang ;
Quarles, L. Darryl .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (03) :658-664
[4]   Klotho insufficiency causes decrease of ribosomal RNA gene transcription activity, cytoplasmic RNA and rough ER in the spinal anterior horn cells [J].
Anamizu, Y ;
Kawaguchi, H ;
Seichi, A ;
Yamaguchi, S ;
Kawakami, E ;
Kanda, N ;
Matsubara, S ;
Kuro-o, M ;
Nabeshima, Y ;
Nakamura, K ;
Oyanagi, K .
ACTA NEUROPATHOLOGICA, 2005, 109 (05) :457-466
[5]   Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleoticle pyrophosphatase phosphodiesterase 1 double-deficient mice [J].
Anderson, HC ;
Harmey, D ;
Camacho, NP ;
Garimella, R ;
Sipe, JB ;
Tague, S ;
Bi, XH ;
Johnson, K ;
Terkeltaub, R ;
Millán, JL .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (06) :1711-1720
[6]   A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis [J].
Araya, K ;
Fukumoto, S ;
Backenroth, R ;
Takeuchi, Y ;
Nakayama, K ;
Ito, N ;
Yoshii, N ;
Yamazaki, Y ;
Yamashita, T ;
Silver, J ;
Igarashi, T ;
Fujita, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (10) :5523-5527
[7]   Early lethality in Hyp mice with targeted deletion of Pth gene [J].
Bai, Xiuying ;
Miao, Dengshun ;
Goltzman, David ;
Karaplis, Andrew C. .
ENDOCRINOLOGY, 2007, 148 (10) :4974-4983
[8]   Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders [J].
Bai, XY ;
Miao, DS ;
Li, JR ;
Goltzman, D ;
Karaplis, AC .
ENDOCRINOLOGY, 2004, 145 (11) :5269-5279
[9]   The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency [J].
Bai, XY ;
Miao, DS ;
Goltzman, D ;
Karaplis, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9843-9849
[10]   Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis [J].
Barbieri, Anna Maria ;
Filopanti, Marcello ;
Bua, Guido ;
Beck-Peccoz, Paolo .
JOURNAL OF HUMAN GENETICS, 2007, 52 (05) :464-468